• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在亚叶酸存在的情况下,氟嘧啶对人癌细胞的细胞毒性呈现出时间依赖性增强。

Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.

作者信息

Moran R G, Scanlon K L

机构信息

Department of Biochemistry, University of Southern California, Los Angeles 90033.

出版信息

Cancer Res. 1991 Sep 1;51(17):4618-23.

PMID:1831402
Abstract

Previous studies from this laboratory indicated that the cytotoxic effects of the fluoropyrimidines on mouse leukemic cells are substantially augmented by folinic acid but that these effects are underestimated in growth inhibition experiments. These results have now been extended to two human tumor cell lines, the WiDr colorectal and T-24 bladder carcinoma cells. In both cell lines, the presence of folinic acid in the medium substantially enhanced the cytotoxicity of a 72-h exposure to either 5-fluorouracil (FUra) or 5-fluoro-2'-deoxyuridine. Folinic acid concentration-response curves for enhancement of the cytotoxicity of FUra to WiDr cells were broad but indicated that response was not maximal until at least 10 microM. Likewise, increased length of exposure to 10 microM folinic acid continuously enhanced the cytotoxicity of a 72-h treatment with FUra, but substantial enhancement was observed even after a 2-h exposure to folinate, and there was a diminished increment of cytotoxicity after 24-h exposure to folinic acid. Surprisingly, folinic acid augmentation of the cytotoxicity of a brief exposure to FUra (4 h) was minimal but enhancement of FUra cytotoxicity became much more pronounced with intervals of exposure to FUra of greater than or equal to 24 h. If these results can be mimicked in vivo without undue host toxicity, our experiments suggest that a substantial improvement in the therapeutic activity of FUra plus folinate would result from prolonged exposure to both agents.

摘要

该实验室之前的研究表明,甲酰四氢叶酸可显著增强氟嘧啶对小鼠白血病细胞的细胞毒性作用,但在生长抑制实验中这些作用被低估了。现在这些结果已扩展至两种人类肿瘤细胞系,即WiDr结肠癌细胞和T-24膀胱癌细胞。在这两种细胞系中,培养基中存在甲酰四氢叶酸可显著增强72小时暴露于5-氟尿嘧啶(FUra)或5-氟-2'-脱氧尿苷后的细胞毒性。甲酰四氢叶酸增强FUra对WiDr细胞细胞毒性的浓度-反应曲线较宽,但表明至少在10微摩尔时反应才达到最大值。同样,延长暴露于10微摩尔甲酰四氢叶酸的时间可持续增强FUra 72小时处理后的细胞毒性,但即使在暴露于甲酰四氢叶酸2小时后也观察到显著增强,且在暴露于甲酰四氢叶酸24小时后细胞毒性的增量有所减少。令人惊讶的是,短暂暴露于FUra(4小时)时甲酰四氢叶酸对细胞毒性的增强作用最小,但当暴露于FUra的间隔时间大于或等于24小时时,FUra细胞毒性的增强变得更加明显。如果这些结果能在体内得以模拟且不会对宿主产生过度毒性,我们的实验表明,延长两种药物的暴露时间将使FUra加甲酰四氢叶酸的治疗活性得到显著改善。

相似文献

1
Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.在亚叶酸存在的情况下,氟嘧啶对人癌细胞的细胞毒性呈现出时间依赖性增强。
Cancer Res. 1991 Sep 1;51(17):4618-23.
2
Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.亚叶酸增强氟嘧啶对小鼠和人类白血病细胞的作用。
Cancer Res. 1986 Oct;46(10):5229-35.
3
Biochemical rationale for the synergism of 5-fluorouracil and folinic acid.5-氟尿嘧啶与亚叶酸协同作用的生化原理。
NCI Monogr. 1987(5):159-63.
4
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.人结肠癌细胞长期暴露于氟尿嘧啶时细胞毒性的决定因素。
Oncol Res. 1997;9(2):77-88.
5
Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Anticancer Res. 1993 Nov-Dec;13(6A):2201-6.
6
Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Cancer Treat Rep. 1987 Apr;71(4):381-9.
7
[Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Gan To Kagaku Ryoho. 1995 Nov;22(13):1927-32.
8
Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.亚叶酸在5-氟尿嘧啶诱导的体外杀伤人类肿瘤细胞系中的双重作用。
Anticancer Res. 1996 Sep-Oct;16(5A):2713-7.
9
Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.由北中部癌症治疗组和梅奥诊所开展的关于亚叶酸对晚期结直肠癌患者5-氟尿嘧啶进行生化调节的临床研究。
NCI Monogr. 1987(5):185-8.
10
Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.双嘧达莫增强5-氟尿嘧啶对人结肠癌细胞的细胞毒性作用
Cancer Res. 1985 Jul;45(7):2967-72.

引用本文的文献

1
Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo.同时(而非连续)与亚叶酸联合使用可增强5-氟尿嘧啶在体外和体内的抗肿瘤活性。
Oncol Res. 2017 Aug 7;25(7):1129-1140. doi: 10.3727/096504017X14841698396900. Epub 2017 Jan 20.
2
Mismatch repair deficient colorectal cancer in the era of personalized treatment.错配修复缺陷型结直肠癌的个体化治疗时代。
Nat Rev Clin Oncol. 2010 Apr;7(4):197-208. doi: 10.1038/nrclinonc.2010.18. Epub 2010 Feb 23.
3
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
一项针对晚期胰腺腺癌患者的大剂量24小时持续输注5-氟尿嘧啶、亚叶酸钙及低剂量丙氨酸磷酸核糖转移酶抑制剂的II期研究:一项西南肿瘤协作组研究
Invest New Drugs. 2004 Aug;22(3):335-41. doi: 10.1023/B:DRUG.0000026261.76197.54.
4
Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity.奥沙利铂-5-氟尿嘧啶-亚叶酸联合用药对药物活性各自细胞内决定因素的影响。
Br J Cancer. 2002 Apr 8;86(7):1162-8. doi: 10.1038/sj.bjc.6600185.
5
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.在接受5-氟尿嘧啶、亚叶酸和α干扰素治疗的晚期癌症患者中,诱导胸苷磷酸化酶作为药效学终点。
Br J Cancer. 2000 Jul;83(2):219-24. doi: 10.1054/bjoc.2000.1230.
6
Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer.
Pharm World Sci. 1999 Aug;21(4):184-9. doi: 10.1023/a:1008671129128.
7
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.
Invest New Drugs. 1997;15(2):139-45. doi: 10.1023/a:1005812923473.
8
Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.交替推注和持续输注5-氟尿嘧啶:一种克服晚期结直肠癌患者对这种氟嘧啶耐药性的策略。
Cytotechnology. 1996;19(3):215-9. doi: 10.1007/BF00744215.
9
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.如何优化5-氟尿嘧啶调节疗法在晚期结直肠癌中的疗效。
Med Oncol. 1995 Sep;12(3):187-201. doi: 10.1007/BF01571196.
10
A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer.一项针对晚期结直肠癌患者的每周输注5-氟尿嘧啶联合低剂量亚叶酸的II期试验。
Invest New Drugs. 1995;13(3):229-33. doi: 10.1007/BF00873805.